Abigene, a Prospective, Multicentric Study of Abiraterone Acetate Pharmacogenetics in Metastatic Castration-Resistant Prostate Cancer †

Abiraterone acetate (AA) is the first-in-class of drugs belonging to the second-generation of agents inhibiting androgen neosynthesis in advanced prostate cancer. A cumulative experience attests that germinal gene polymorphisms may play a role in the prediction of anticancer agent pharmacodynamics v...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrero, Jean-Marc, Mahammedi, Hakim, Gravis, Gwenaelle, Roubaud, Guilhem, Beuzeboc, Philippe, Largillier, Remi, Borchiellini, Delphine, Linassier, Claude, Ebran, Nathalie, Pace-Loscos, Tanguy, Etienne-Grimaldi, Marie-Christine, Schiappa, Renaud, Gal, Jocelyn, Milano, Gérard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959353/
https://www.ncbi.nlm.nih.gov/pubmed/36839973
http://dx.doi.org/10.3390/pharmaceutics15020651

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959353/
https://www.ncbi.nlm.nih.gov/pubmed/36839973
http://dx.doi.org/10.3390/pharmaceutics15020651

Ejemplares similares